Jim Simons Fortress Biotech, Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.28 - $0.65 $26,656 - $61,880	95,200 Added 41.68%	323,627 $94,000
Q2 2023 Aug 11, 2023	SELL	$0.49 - $0.82 $11,795 - $19,739	-24,073 Reduced 9.53%	228,427 $126,000
Q1 2023 May 12, 2023	BUY	$0.65 - $1.1 $5,980 - $10,120	9,200 Added 3.78%	252,500 $207,000
Q4 2022 Feb 13, 2023	SELL	$0.48 - $0.88 $94,698 - $173,614	-197,289 Reduced 44.78%	243,300 $159,000
Q3 2022 Nov 14, 2022	SELL	$0.79 - $22.0 $98,363 - $2.74 Million	-124,511 Reduced 22.03%	440,589 $379,000

Q2 2022 Aug 12, 2022	SELL	$0.8 - $1.5 $428,960 - $804,300	-536,200 Reduced 48.69%	565,100 $475,000
Q1 2022 May 13, 2022	BUY	$1.24 - $2.75 $1.24 Million - $2.75 Million	1,001,653 Added 1005.2%	1,101,300 $1.5 Million
Q4 2021 Feb 11, 2022	BUY	$2.42 - $3.65 $241,145 - $363,711	99,647 New	99,647 $249,000
Q4 2020 Feb 10, 2021	SELL	$2.2 - $4.45 $65,573 - $132,636	-29,806 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.62 - $4.78 $1.5 Million - $2.74 Million	-574,200 Reduced 95.07%	29,806 $120,000
Q2 2020 Aug 13, 2020	BUY	$1.83 - $3.16 $191,235 - $330,220	104,500 Added 20.92%	604,006 $1.62 Million
Q1 2020 May 14, 2020	BUY	$1.14 - $2.96 $149,802 - $388,961	131,406 Added 35.7%	499,506 $944,000
Q4 2019 Feb 13, 2020	BUY	$1.25 - $2.57 $239,351 - $492,106	191,481 Added 108.41%	368,100 $946,000
Q3 2019 Nov 13, 2019	BUY	$1.26 - $1.96 $201,713 - $313,776	160,090 Added 968.54%	176,619 $249,000
Q2 2019 Aug 12, 2019	BUY	$1.43 - $1.94 $23,636 - $32,066	16,529 New	16,529 $25,000
Q1 2019 May 14, 2019	SELL	$0.94 - $2.47 $152,987 - $401,999	-162,753 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$0.57 - $1.53 $92,769 - $249,012	162,753 New	162,753 $140,000

Others Institutions Holding FBIO

# of Institutions

Shares Held

1.01M

Call Options Held

Put Options Held

View Full List

About Fortress Biotech, Inc.

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $194M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

More about FBIO

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account